When was Formial Labs founded?

Formial Labs was founded in 2024.

Where is Formial Labs located?

Formial Labs is headquartered in Bengaluru, India.

How many employees does Formial Labs have?

As of Aug 31, 2026, the latest employee count at Formial Labs is 9.

Where does Formial Labs rank among its competitors?

Formial Labs ranks 91st amongst 78 active competitors, of which 21 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneel, which secured $10.5M in Jun, 2026.

Who are the top competitors of Formial Labs?

Formial Labs' top competitors include Immuneel, Kult and Brinton Pharmaceuticals. Among them, Immuneel secured the most recent funding round in June, 2026.

Formial Labs - 2026 Company Profile, Team & Competitors

Formial Labs is an unfunded company based in Bengaluru (India), founded in 2024 by Jeet Patel. It operates as a Provider of personalized prescription skincare formulations based on medical assessments. Formial Labs has not raised any funding yet. The company has 78 active competitors, including 21 funded and 6 that have exited. Its top competitors include companies like Immuneel, Kult and Brinton Pharmaceuticals.

Company Details

Provider of personalized prescription skincare formulations based on medical assessments. Licensed dermatologists review individual skin profiles to create compounded treatments for conditions including acne, pigmentation, scarring, and aging. These formulations utilize active ingredients to address specific dermatological concerns. The process involves an online consultation followed by the delivery of treatment plans that are adjusted based on progress. The service includes ongoing support to monitor skin changes and modify prescriptions as necessary.

Key Metrics

Founded Year

2024

Location

Bengaluru, India

Stage

Unfunded

Ranked

91^st among 91 competitors

Employee Count

9 as on Aug 31, 2026

Similar Companies

LEO Pharma & 216 more

View Formial Labs' full profile

Formial Labs has not raised any funding rounds yet.

The founders of Formial Labs is Jeet Patel.

Here are the details of Formial Labs' key team members:

Jeet Patel: Founder of Formial Labs.
Contact Info: 1 email address

View details of Formial Labs's Founder profiles and Board Members

Formial Labs' employee count trend

Formial Labs has 9 employees as of Aug 26. Here is Formial Labs's employee count trend over the years:

Uncover Formial Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Formial Labs include Immuneel, Kult and Brinton Pharmaceuticals. Here is the list of Top 10 competitors of Formial Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	71/100
2nd	Kult 2019, Thane (India), Series A	App-based platform offering personalized beauty care recommendations	$24.8M	Mercuri, Massons Realtors and Developers & 4 others	67/100
3rd	Brinton Pharmaceuticals 2014, Pune (India), Series A	Manufacturer of dermatology gastroenterology and wellness pharmaceutical products	$16.9M	BlackSoil, IDBI trustee & 16 others	67/100
4th	Tesaro 2010, Waltham (United States), Acquired	Global biopharma innovating medicines in respiratory, immunology, oncology, HIV, and infectious diseases	$161M	Kleiner Perkins, New Enterprise Associates ... & 14 others	66/100
5th	Vyome Therapeutics 2010, Princeton (United States), Public	Developer of therapeutics for the immuno-inflammatory conditions	$62.9M	Perceptive Advisors, Sabre Partners & 11 others	57/100
6th	Sekkei Bio 2017, Chennai (India), Series A	Developer of drugs and vaccines to treat multiple diseases	$2.03M	Tenshi Life Sciences, Gates & 5 others	52/100
7th	Aurigene 2001, Bengaluru (India), Unfunded	Clinical-stage biotech company specializing in the discovery and development of novel therapeutics for cancer treatment	-	-	51/100
8th	Mitra Biotech 2010, Woburn (United States), Series B	Biotechnology company focused on advancing personalized cancer treatment through its clinically validated oncology drug efficacy platform, CANscript	$40.7M	Sequoia Capital, Sands Capital Ventures & 7 others	49/100
9th	Bugworks Research 2014, Bengaluru (India), Series B	Developer of drugs for antibiotic-resistant bacterial infections and cancer	$42.9M	UTEC, Lightrock India & 20 others	48/100
10th	Sathgen Therapeutics 2007, Mumbai (India), Unfunded	Developer of therapeutics for cancer and viral infection	-	-	47/100
91st	Formial Labs 2024, Bengaluru (India), Unfunded	Provider of personalized prescription skincare formulations based on medical assessments	-	-	25/100